Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of MN-10-T for primary osteoporosis
jRCT2080220434Phase 3
- Sponsor
- Asahi Kasei Corporation
- Start
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of ZT-034 in involutional osteoporosis, sponsored by Asahi Kasei Corporation.
02
Drugs
ZT-034
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on jRCT2080220434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220434.